Skip to content

Oramed to Start Oral Covid-19 Vaccine Trial in South Africa

  • Dose would be the first using oral delivery in the country
  • Phase 1 has clearance from the country’s health regulators
Updated on

Sign up to our Next Africa newsletter and follow Bloomberg Africa on Twitter

Oramed Pharmaceuticals Inc. won approval to run an initial clinical trial for its orally delivered Covid-19 vaccine candidate in South Africa.